1317 related items for PubMed ID: 17533019
1. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP.
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[Abstract] [Full Text] [Related]
2. Primary glomerulonephritis: an update on renal survival and determinants of progression.
Moranne O, Watier L, Rossert J, Stengel B, GN-Progress Study Group.
QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
[Abstract] [Full Text] [Related]
3. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[Abstract] [Full Text] [Related]
4. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T, Nakao H.
Ren Fail; 2005 Jun; 27(1):45-52. PubMed ID: 15717634
[Abstract] [Full Text] [Related]
5. Factors predicting progression of IgA nephropathies.
Coppo R, D'Amico G.
J Nephrol; 2005 Jun; 18(5):503-12. PubMed ID: 16299675
[Abstract] [Full Text] [Related]
6. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.
Wakai K, Kawamura T, Endoh M, Kojima M, Tomino Y, Tamakoshi A, Ohno Y, Inaba Y, Sakai H.
Nephrol Dial Transplant; 2006 Oct; 21(10):2800-8. PubMed ID: 16822793
[Abstract] [Full Text] [Related]
7. Cigarette smoking and progression of IgA nephropathy.
Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Hamano T, Kawada N, Inoue K, Uehata T, Kaneko T, Okada N, Moriyama T, Horio M, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y.
Am J Kidney Dis; 2010 Aug; 56(2):313-24. PubMed ID: 20471735
[Abstract] [Full Text] [Related]
8. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
Espinosa M, Ortega R, Gómez-Carrasco JM, López-Rubio F, López-Andreu M, López-Oliva MO, Aljama P.
Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
[Abstract] [Full Text] [Related]
9. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.
Jafar TH, Schmid CH, Stark PC, Toto R, Remuzzi G, Ruggenenti P, Marcantoni C, Becker G, Shahinfar S, De Jong PE, De Zeeuw D, Kamper AL, Strangaard S, Levey AS.
Nephrol Dial Transplant; 2003 Oct; 18(10):2047-53. PubMed ID: 13679479
[Abstract] [Full Text] [Related]
10. Tubular lesions determine prognosis of IgA nephropathy.
Daniel L, Saingra Y, Giorgi R, Bouvier C, Pellissier JF, Berland Y.
Am J Kidney Dis; 2000 Jan; 35(1):13-20. PubMed ID: 10620538
[Abstract] [Full Text] [Related]
11. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS.
Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
[Abstract] [Full Text] [Related]
12. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T, Najafi I, Salimi BH, Broomand B.
Ren Fail; 2011 Feb; 33(6):572-7. PubMed ID: 21663387
[Abstract] [Full Text] [Related]
13. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
Komatsu H, Fujimoto S, Sato Y, Hara S, Yamada K, Morita S, Eto T.
J Nephrol; 2005 Feb; 18(6):690-5. PubMed ID: 16358226
[Abstract] [Full Text] [Related]
14. [A cumulative renal survival analysis of 495 cases of IgA nephropathy].
Qin Y, Li XW, Li H, Duan L, Li Y.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):160-3. PubMed ID: 15171553
[Abstract] [Full Text] [Related]
15. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G.
J Nephrol; 2009 Apr; 22(3):387-96. PubMed ID: 19557716
[Abstract] [Full Text] [Related]
16. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[Abstract] [Full Text] [Related]
17. Prognostic factors in immunoglobulin-A nephropathy.
Muthukumar T, Fernando ME, Jayakumar M.
J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461
[Abstract] [Full Text] [Related]
18. Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis.
Kapitsinou PP, Ioannidis JP, Boletis JN, Sotsiou F, Nakopoulou L, Daphnis E, Moutsopoulos HM.
Am J Kidney Dis; 2003 Jan; 41(1):29-37. PubMed ID: 12500219
[Abstract] [Full Text] [Related]
19. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
Kawamura T, Joh K, Okonogi H, Koike K, Utsunomiya Y, Miyazaki Y, Matsushima M, Yoshimura M, Horikoshi S, Suzuki Y, Furusu A, Yasuda T, Shirai S, Shibata T, Endoh M, Hattori M, Katafuchi R, Hashiguchi A, Kimura K, Matsuo S, Tomino Y, Study Group Special IgA Nephropathy.
J Nephrol; 2013 Jan; 26(2):350-7. PubMed ID: 22684645
[Abstract] [Full Text] [Related]
20. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
Tang Z, Ji SM, Chen DR, Wen JQ, Chen JS, Liu ZH, Li LS.
Ren Fail; 2008 Jan; 30(6):611-6. PubMed ID: 18661411
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
